These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 11113464)

  • 21. The OSIRIS Weight of Evidence approach: ITS mutagenicity and ITS carcinogenicity.
    Buist H; Aldenberg T; Batke M; Escher S; Klein Entink R; Kühne R; Marquart H; Pauné E; Rorije E; Schüürmann G; Kroese D
    Regul Toxicol Pharmacol; 2013 Nov; 67(2):170-81. PubMed ID: 23357514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EURL ECVAM Genotoxicity and Carcinogenicity Database of Substances Eliciting Negative Results in the Ames Test: Construction of the Database.
    Madia F; Kirkland D; Morita T; White P; Asturiol D; Corvi R
    Mutat Res Genet Toxicol Environ Mutagen; 2020; 854-855():503199. PubMed ID: 32660827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rational approach to the quantification of genotoxicity.
    Benigni R
    Environ Mol Mutagen; 1992; 19(1):83-9. PubMed ID: 1732108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of carcinogenic and in vivo genotoxic potency estimates.
    Sanner T; Dybing E
    Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
    Bolt HM; Foth H; Hengstler JG; Degen GH
    Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutagenicity testing for chemical risk assessment: update of the WHO/IPCS Harmonized Scheme.
    Eastmond DA; Hartwig A; Anderson D; Anwar WA; Cimino MC; Dobrev I; Douglas GR; Nohmi T; Phillips DH; Vickers C
    Mutagenesis; 2009 Jul; 24(4):341-9. PubMed ID: 19535363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The lacI transgenic mouse mutagenicity assay: quantitative evaluation in comparison to tests for carcinogenicity and cytogenetic damage in vivo.
    Shephard SE; Lutz WK; Schlatter C
    Mutat Res; 1994 Apr; 306(2):119-28. PubMed ID: 7512210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of predictivity of volatile organic compounds carcinogenicity and mutagenicity by freeware in silico models.
    Guerra LR; de Souza AMT; Côrtes JA; Lione VOF; Castro HC; Alves GG
    Regul Toxicol Pharmacol; 2017 Dec; 91():1-8. PubMed ID: 28970106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutagens that are not carcinogens: faulty theory or faulty tests?
    Zeiger E
    Mutat Res; 2001 May; 492(1-2):29-38. PubMed ID: 11377241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated approach to testing and assessment for predicting rodent genotoxic carcinogenicity.
    Petkov PI; Schultz TW; Donner EM; Honma M; Morita T; Hamada S; Wakata A; Mishima M; Maniwa J; Todorov M; Kaloyanova E; Kotov S; Mekenyan OG
    J Appl Toxicol; 2016 Dec; 36(12):1536-1550. PubMed ID: 27225589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rodent carcinogenicity and toxicity, in vitro mutagenicity, and their physical chemical determinants.
    Benigni R; Andreoli C
    Mutat Res; 1993 Oct; 297(3):281-92. PubMed ID: 7692274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The equivalence of assays within individual guidelines for the testing of the potential mutagenicity of chemicals: problems associated with battery selection.
    Parry JM
    Mutat Res; 1988; 205(1-4):385-92. PubMed ID: 3285196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carcinogenicity of the aromatic amines: from structure-activity relationships to mechanisms of action and risk assessment.
    Benigni R; Passerini L
    Mutat Res; 2002 Jul; 511(3):191-206. PubMed ID: 12088717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proposed integrated decision-tree testing strategies for mutagenicity and carcinogenicity in relation to the EU REACH legislation.
    Combes R; Grindon C; Cronin MT; Roberts DW; Garrod J
    Altern Lab Anim; 2007 May; 35(2):267-87. PubMed ID: 17559315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mutagenicity of natural-origin agents carcinogenic to humans].
    Nersesian AK
    Eksp Onkol; 1990; 12(1):3-6. PubMed ID: 2404738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP.
    Ashby J; Tennant RW
    Mutat Res; 1991 May; 257(3):229-306. PubMed ID: 1707500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transformation of BALB/c-3T3 cells: V. Transformation responses of 168 chemicals compared with mutagenicity in Salmonella and carcinogenicity in rodent bioassays.
    Matthews EJ; Spalding JW; Tennant RW
    Environ Health Perspect; 1993 Jul; 101 Suppl 2(Suppl 2):347-482. PubMed ID: 8243403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.